We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,266 hedge funds and large institutions have $176B invested in Thermo Fisher Scientific in 2022 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 927 increasing their positions, 863 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 102

13% more call options, than puts

Call options by funds: $1.47B | Put options by funds: $1.3B

7% more repeat investments, than reductions

Existing positions increased: 927 | Existing positions reduced: 863

0.97% more ownership

Funds ownership: 87.64%88.62% (+0.97%)

1% less funds holding

Funds holding: 2,2812,266 (-15)

5% less capital invested

Capital invested by funds: $186B → $176B (-$9.79B)

6% less funds holding in top 10

Funds holding in top 10: 253238 (-15)

Holders
2,266
Holders Change
-15
Holders Change %
-0.66%
% of All Funds
39.04%
Holding in Top 10
238
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-5.93%
% of All Funds
4.1%
New
116
Increased
927
Reduced
863
Closed
102
Calls
$1.47B
Puts
$1.3B
Net Calls
+$166M
Net Calls Change
+$177M
Name Holding Trade Value Shares
Change
Change in
Stake
PTC
1001
Private Trust Company
Ohio
$2.72M -$117K -209 -4%
CF
1002
Centaurus Financial
California
$2.68M +$222K +397 +8%
BLC
1003
Brown, Lisle/Cummings
Rhode Island
$2.68M -$19.6K -35 -0.7%
APA
1004
American Portfolios Advisors
New York
$2.66M -$81.7K -146 -3%
RPC
1005
Rossmore Private Capital
Connecticut
$2.66M +$12.3K +22 +0.4%
AWM
1006
Angeles Wealth Management
California
$2.65M +$226K +404 +8%
TPW
1007
Transatlantique Private Wealth
New York
$2.64M +$254K +453 +10%
RP
1008
Regal Partners
Australia
$2.64M
HWM
1009
HB Wealth Management
Georgia
$2.63M +$45.3K +81 +2%
PK
1010
Pflug Koory
Nebraska
$2.62M
WP
1011
WealthSpring Partners
California
$2.61M +$2.88M +5,152 New
BS
1012
Bessemer Securities
New York
$2.6M -$220K -393 -7%
AWM
1013
Aries Wealth Management
Maine
$2.6M +$61.6K +110 +2%
CGL
1014
Clarius Group LLC
Washington
$2.6M +$121K +216 +4%
HH
1015
Hilltop Holdings
Texas
$2.6M +$1.53M +2,729 +114%
FDS
1016
Freedom Day Solutions
Texas
$2.58M +$15.7K +28 +0.6%
HFG
1017
Heron Financial Group
New York
$2.58M
LA
1018
Legacy Advisors
Pennsylvania
$2.57M +$374K +668 +15%
PCIA
1019
Prime Capital Investment Advisors
Kansas
$2.57M -$8.05M -14,389 -74%
VIA
1020
Vident Investment Advisory
Georgia
$2.57M +$201K +359 +7%
CG
1021
Caprock Group
Idaho
$2.56M +$321K +574 +13%
AWM
1022
Avitas Wealth Management
California
$2.56M +$15.1K +27 +0.5%
DAS
1023
Dynamic Advisor Solutions
Arizona
$2.56M +$182K +326 +7%
CIA
1024
Cohen Investment Advisors
New Hampshire
$2.54M -$45.3K -81 -2%
AW
1025
ACG Wealth
Georgia
$2.54M -$1.03M -1,844 -27%

TMO Hedge Fund Activity: Q3 2022 in Review

2,266 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2022, worth a combined $176B — down 5.3% from $186B a quarter earlier.

Buyers outnumbered sellers: 116 funds opened new TMO positions and 102 closed out — a net gain of 14 holders — while 927 added to existing stakes and 863 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $795M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.12B.

  • 2,266 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2022, down from 2,281 in Q2 2022.
  • Funds reported $176B of Thermo Fisher Scientific stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 116 funds opened new Thermo Fisher Scientific positions in Q3 2022 and 102 closed out, a net change of +14 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2022 was Janus Henderson Group, an estimated $795M added.
  • The largest Thermo Fisher Scientific seller in Q3 2022 was T. Rowe Price Associates, an estimated $2.12B sold.

Based on aggregated 13F filings for Q3 2022.